FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

398941005: Product containing hydrochlorothiazide and methyldopa (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3490632013 Product containing hydrochlorothiazide and methyldopa (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3715159017 Hydrochlorothiazide- and methyldopa-containing product en Synonym Active Entire term case insensitive SNOMED CT core module


7 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing hydrochlorothiazide and methyldopa Is a Product containing methyldopa true Inferred relationship Existential restriction modifier
Product containing hydrochlorothiazide and methyldopa Is a Product containing hydrochlorothiazide true Inferred relationship Existential restriction modifier
Product containing hydrochlorothiazide and methyldopa Has active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier 2
Product containing hydrochlorothiazide and methyldopa Has active ingredient Methyldopa true Inferred relationship Existential restriction modifier 1
Product containing hydrochlorothiazide and methyldopa Has active ingredient Centrally acting hypotensive agent false Inferred relationship Existential restriction modifier
Product containing hydrochlorothiazide and methyldopa Plays role Diuretic therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely hydrochlorothiazide 15 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Is a False Product containing hydrochlorothiazide and methyldopa Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 25 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Is a False Product containing hydrochlorothiazide and methyldopa Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 30 milligram and methyldopa 500 milligram/1 each conventional release oral tablet Is a False Product containing hydrochlorothiazide and methyldopa Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 50 milligram and methyldopa 500 milligram/1 each conventional release oral tablet Is a False Product containing hydrochlorothiazide and methyldopa Inferred relationship Existential restriction modifier
Product containing hydrochlorothiazide and methyldopa in oral dose form (medicinal product form) Is a True Product containing hydrochlorothiazide and methyldopa Inferred relationship Existential restriction modifier
Product containing only hydrochlorothiazide and methyldopa (medicinal product) Is a True Product containing hydrochlorothiazide and methyldopa Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start